Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Imagion Biosystems Ltd. ( (AU:IBX) ).
Imagion Biosystems announced an update to its Securities Trading Policy, adhering to ASX Listing Rules to ensure confidence in its operations and securities trading. The revision reflects the company’s commitment to transparency and regulatory compliance, potentially strengthening its credibility among stakeholders and investors.
The most recent analyst rating on (AU:IBX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Imagion Biosystems Ltd. stock, see the AU:IBX Stock Forecast page.
More about Imagion Biosystems Ltd.
Imagion Biosystems is a healthcare-focused company combining biotechnology and nanotechnology to develop MagSense® imaging technology. This non-radioactive, precision diagnostic molecular imaging technology aims to improve early detection and specificity in diagnosing cancer and other diseases.
Average Trading Volume: 5,712,997
Technical Sentiment Signal: Sell
Current Market Cap: A$10.7M
Learn more about IBX stock on TipRanks’ Stock Analysis page.